NO893196D0 - Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling. - Google Patents

Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.

Info

Publication number
NO893196D0
NO893196D0 NO893196A NO893196A NO893196D0 NO 893196 D0 NO893196 D0 NO 893196D0 NO 893196 A NO893196 A NO 893196A NO 893196 A NO893196 A NO 893196A NO 893196 D0 NO893196 D0 NO 893196D0
Authority
NO
Norway
Prior art keywords
hybrid
protein
procedures
compositions
preparation
Prior art date
Application number
NO893196A
Other languages
English (en)
Other versions
NO893196L (no
Inventor
Tamotsu Hashimoto
Mikiko Takahashi
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of NO893196D0 publication Critical patent/NO893196D0/no
Publication of NO893196L publication Critical patent/NO893196L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO89893196A 1988-08-09 1989-08-08 Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling. NO893196L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63197144A JPH0246296A (ja) 1988-08-09 1988-08-09 雑種プロテインｃ及びその製造方法

Publications (2)

Publication Number Publication Date
NO893196D0 true NO893196D0 (no) 1989-08-08
NO893196L NO893196L (no) 1990-02-12

Family

ID=16369490

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893196A NO893196L (no) 1988-08-09 1989-08-08 Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.

Country Status (9)

Country Link
EP (1) EP0354504A2 (no)
JP (1) JPH0246296A (no)
KR (1) KR900002795A (no)
AU (1) AU3937289A (no)
DK (1) DK388789A (no)
FI (1) FI893724L (no)
IL (1) IL91234A0 (no)
NO (1) NO893196L (no)
PT (1) PT91391A (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991009960A1 (en) * 1989-12-29 1991-07-11 Zymogenetics, Inc. Hybrid protein c
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
JPH04127174U (ja) * 1991-05-09 1992-11-19 株式会社シマノ 釣り用リール
US5618714A (en) * 1993-12-15 1997-04-08 Eli Lilly And Company Methods for producing protein C
US5847085A (en) * 1996-11-08 1998-12-08 Oklahoma Medical Research Foundation Modified protein C and methods of use thereof
US6017882A (en) * 1997-10-23 2000-01-25 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6747003B1 (en) 1997-10-23 2004-06-08 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6693075B1 (en) 1997-10-23 2004-02-17 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US7247708B2 (en) 1997-10-23 2007-07-24 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6998122B1 (en) 1999-04-30 2006-02-14 Eli Lilly And Company Protein C derivatives
US6841371B2 (en) 2000-02-02 2005-01-11 Eli Lilly And Company Protein C derivatives
EP1263943A1 (en) 2000-02-11 2002-12-11 Eli Lilly & Company Protein c derivatives
CA2739933A1 (en) 2000-02-11 2001-08-16 Bayer Healthcare Llc Factor vii or viia-like molecules
US7220837B1 (en) 2000-04-28 2007-05-22 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US7812132B2 (en) 2000-04-28 2010-10-12 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US20030211094A1 (en) 2001-06-26 2003-11-13 Nelsestuen Gary L. High molecular weight derivatives of vitamin k-dependent polypeptides
CA2440092A1 (en) * 2001-03-02 2002-09-12 T.A.C. Thrombosis And Coagulation Ab Protein c variants
CN1665925A (zh) 2002-04-30 2005-09-07 马克西根控股公司 凝血因子Ⅶ或Ⅶa多肽变体
DE602004021099D1 (de) 2003-03-20 2009-06-25 Bayer Healthcare Llc Fvii oder fviia varianten
CN1839203B (zh) 2003-06-19 2011-11-16 拜耳医药保健有限公司 因子VII或VIIa的GLA结构域变体

Also Published As

Publication number Publication date
AU3937289A (en) 1990-04-12
FI893724A0 (fi) 1989-08-07
KR900002795A (ko) 1990-03-23
DK388789D0 (da) 1989-08-08
IL91234A0 (en) 1990-03-19
FI893724A7 (fi) 1990-02-10
JPH0246296A (ja) 1990-02-15
NO893196L (no) 1990-02-12
PT91391A (pt) 1990-03-08
FI893724L (fi) 1990-02-10
DK388789A (da) 1990-02-10
EP0354504A2 (en) 1990-02-14

Similar Documents

Publication Publication Date Title
NO893678L (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO881660D0 (no) Hepariner og femgangsmaate for deres fremstilling.
NO900577D0 (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO903928D0 (no) Metallocenforbindelser og fremgangsmaate for deres fremstilling.
NO882390D0 (no) (ih-azol-1-ylmetyl)substituerte benzotriazolderivater og deres fremstilling.
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
NO892745D0 (no) Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling.
NO875358L (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
NO870512D0 (no) 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling.
NO910003L (no) Vitamin e-derivater og fremgangsmaate for deres fremstilling.
NO902279L (no) Benzocykloalkanderivater og deres fremstilling.
NO894624L (no) Kopolymerer og fremgangsmaate for deres fremstilling.
NO895030D0 (no) 2-imino-benzotiazolinderivater og deres fremstilling.
NO903096L (no) Termotrope semialifatiske kopolyesteramider og deres fremstilling.
DK393489A (da) Benzodiazepinforbindelser og fremgangsmaade til deres fremstilling
NO883114L (no) 1h-pyrazol-1-alkanamider og fremgangsmaate for deres fremstilling.
NO911047L (no) Labdaner og fremgangsmaate for deres fremstilling.
NO893565L (no) Etansulfonamidderivater og fremgangsmaate for deres fremstilling.
NO894697D0 (no) Penemderivater og fremgangsmaater for deres fremstilling.
DK623289A (da) Polymerkompositioner og fremgangsmaade til deres fremstilling
NO873126D0 (no) Cefalosporiner og derivater derav og fremgangsmaater for deres fremstilling.
NO843158L (no) 1,6-nafthydrinderivater og fremgangsmaate for deres fresmtilling
NO904221D0 (no) Polyolefinmodifiserte polyurethan- og polyureamaterialer og fremgangsmaate for deres fremstilling.
DK354688A (da) Benzooe5,6aacycloheptapyridiner, kompositioner og fremgangsmaader til deres anvendelse
NO882925L (no) Stoepte komponenter og deres fremstilling.